News
Bio Europe Hamburg
BIO Europe Hamburg – Tuesday November 12 th from 9am to 10:30 am -Emmanuel Vincent, CEO Aenitis Technologies, will present the experience of Aenitis with the SME instrument
BIO Europe Hamburg – Tuesday November 12 th from 9am to 10:30 am -Emmanuel Vincent, CEO Aenitis Technologies, will present the experience of Aenitis with the SME instrument
Aenitis Technologies has been selected for the €10,000 grant in the EIT Health Summit programme
Aenitis Technologies has been selected for the €10,000 grant in the EIT Health Summit programme
Paris, October 19, 2016 – Aenitis Technologies, a company that develops new medical devices based on acoustic manipulation mechanisms for biological particles, is announcing that FIST SA, the CNRS’ technology exploitation subsidiary, has acquired an interest in its capital France Innovation Scientifique et Transfert SA (FIST SA) has established a stake in the capital of the company founded in July 2014 by Mauricio Hoyos and Jean-Luc Aider, two CNRS research scientists working in the Laboratory of Physics and Mechanics of Heterogeneous Environments (CNRS, ESPCI, UPMC, Université Paris Diderot), and Emmanuel Vincent. Aenitis Technologies is
Paris, July 2, 2015 – Aenitis Technologies : Winner of 17th Contest in Category I-lab Creation Development of the Ministry of Research and Higher Education. Created in July 2014, Aenitis Technologies is a young French start-up from born from the work of Mauricio Hoyos and Jean-Luc AIDER, researchers at the CNRS Laboratory of Physics and Mechanics of Heterogeneous Media (PMMH) at ESPCI. The company focuses its activities in the medical devices sector where the impact of technology breaks it develops strongly wearer.. This significant support from the Ministry of Research and Higher Education will contribute
Acoustic Cell Handling solutions appear in the bioprocessing field. Contactless, pressureless and non-invasive technology, presents plenty of added value to meet the challenges of bioproduction. Do you want to learn more about those new ways to prepare cells in cell and gene processing? On the sidelines of the ISCT 2023 annual meeting in Paris, Aenitis Technologies invites you on the evening of Tuesday, May the 30th, 2023, to an event aimed at giving the keys of these new acoustic approaches. Following the state of the art in the field, a round table of experts from
Les forces de radiations acoustiques mobilisent les cellules en suspension avec une intensité sélective selon leur volume et leur densité en l’absence de contact et de pression. L’acoustophorèse utilise ce principe pour la préparation de concentrés plaquettaires (CP). https://doi.org/10.1016/j.tracli.2021.08.036
Emmanuel Vincent, cofondateur et DG d’Aenitis Technologies a présenté aujourd’hui au Congrès POLEPHARMA Bioproduction 4ème édition Le Rendez-Vous Annuel des acteurs de la Bioproduction Pharmaceutique Les 12 & 13 décembre 2019 au Palais des Congrès de Tours
Une approche innovante pour optimiser les processus de bioproduction, via l’utilisation de la force acoustique, c’est ce que propose la start-up parisienne, hébergée au sein de l’hôpital Saint-Louis, Aenitis Technologies. Focus sur les quatre segments dans lesquels la jeune entreprise compte bien faire son chemin. Acoustophorèse ou lévitation acoustique, telle est le nom de la méthode utilisée par la start-up Aenitis Technologies pour séparer, manipuler et filtrer des particules biologiques. Implantée à l’hôpital Saint-Louis de Paris, « pour disposer de l’expertise en thérapie cellulaire et de tout le matériel biologique nécessaire », comme
